CV Advisors’s Relmada Therapeutics RLMD Stock Holding History

CV Advisors’s Portfolio RLMD Stock Details RLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$75.4K	Buy	+20,000	New	+$98.1K	0.01%	114

Other funds holding RLMD

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CV Advisors's RLMD Position: Q3 2026 in Review

CV Advisors opened a new position in Relmada Therapeutics (RLMD) in Q3 2026: 20,000 shares worth $75.4K. The stake represents 0.01% of the portfolio and ranks #114 among its holdings.

3 funds tracked by Wall St. Rank hold RLMD as of Q3 2026.

CV Advisors held 20,000 shares of Relmada Therapeutics worth $75.4K as of Q3 2026.
Relmada Therapeutics was a new CV Advisors position in Q3 2026.
Relmada Therapeutics made up 0.01% of CV Advisors's portfolio in Q3 2026, its #114 holding.
3 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q3 2026.

Based on CV Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.